Jacobs Levy Equity Management
CMRX

Jacobs Levy Equity Management’s Chimerix, Inc. CMRX Stock Holding History

Jacobs Levy Equity Management’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-436,460
Closed -$420K – 1071
2023
Q4 		$420K Buy
436,460
+217,160
+99% +$210K ﹤0.01% 854
2023
Q3 		$210K Sell
219,300
-1,010,529
-82% -$1.1M ﹤0.01% 921
2023
Q2 		$1.49M Buy
1,229,829
+626,488
+104% +$794K 0.01% 626
2023
Q1 		$760K Sell
603,341
-914,883
-60% -$1.49M ﹤0.01% 745
2022
Q4 		$2.82M Buy
1,518,224
+1,387,961
+1,066% +$2.72M 0.02% 491
2022
Q3 		$251K Buy
+130,263
New +$292K ﹤0.01% 914
2021
Q3 		– Sell
-25,681
Closed -$205K – 1135
2021
Q2 		$205K Buy
25,681
+1,467
+6% +$12.2K ﹤0.01% 986
2021
Q1 		$233K Sell
24,214
-431,451
-95% -$3.96M ﹤0.01% 958
2020
Q4 		$2.2M Sell
455,665
-31,723
-7% -$115K 0.02% 561
2020
Q3 		$1.21M Sell
487,388
-341
-0.1% -$1.01K 0.01% 616
2020
Q2 		$1.51M Buy
487,729
+474,809
+3,675% +$1.23M 0.02% 581
2020
Q1 		$19K Sell
12,920
-563,718
-98% -$987K ﹤0.01% 992
2019
Q4 		$1.17M Buy
576,638
+114,135
+25% +$210K 0.01% 663
2019
Q3 		$1.09M Buy
462,503
+252,808
+121% +$730K 0.01% 607
2019
Q2 		$906K Buy
209,695
+132,708
+172% +$408K 0.01% 657
2019
Q1 		$162K Sell
76,987
-172,812
-69% -$394K ﹤0.01% 913
2018
Q4 		$642K Sell
249,799
-16,802
-6% -$56.3K 0.01% 694
2018
Q3 		$1.04M Buy
266,601
+19,685
+8% +$83.8K 0.01% 642
2018
Q2 		$1.18M Sell
246,916
-27,179
-10% -$130K 0.02% 627
2018
Q1 		$1.43M Buy
274,095
+70,400
+35% +$357K 0.02% 557
2017
Q4 		$943K Buy
203,695
+49,287
+32% +$234K 0.02% 626
2017
Q3 		$811K Buy
154,408
+88,828
+135% +$437K 0.02% 625
2017
Q2 		$357K Buy
65,580
+5,120
+8% +$26.9K 0.01% 744
2017
Q1 		$386K Buy
+60,460
New +$343K 0.01% 691

Other funds holding CMRX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management's CMRX Position: Q1 2024 in Review

Jacobs Levy Equity Management sold out of Chimerix, Inc. (CMRX) in Q1 2024, closing a stake of 436,460 shares — an estimated $420K sold.

Jacobs Levy Equity Management first reported a position in CMRX in Q1 2017 and held it in 24 quarters. The position peaked at $2.82M in Q4 2022. 78 funds tracked by Wall St. Rank hold CMRX as of Q1 2024.

  • Jacobs Levy Equity Management reported no remaining Chimerix, Inc. position as of Q1 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 436,460 Chimerix, Inc. shares in Q1 2024, an estimated $420K.
  • Jacobs Levy Equity Management first reported a position in Chimerix, Inc. in Q1 2017 and held it in 24 quarters.
  • Jacobs Levy Equity Management's Chimerix, Inc. position peaked at $2.82M in Q4 2022.
  • 78 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2024, filed 15 May 2024.